Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Stromal Tumors

Explore clinical trials studying Gastrointestinal Stromal Tumors. Study availability and eligibility vary by location and protocol.

244 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Stromal Tumors trial results

Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

Imatinib TDM in GIST

NCT05493215

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Markey Cancer Center Lexington, Kentucky, United States
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

NCT07585266

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations
  • GSK Investigational Site Canton, Ohio, United States
  • GSK Investigational Site Seoul, South Korea
  • GSK Investigational Site Omaha, Nebraska, United States
  • GSK Investigational Site Knoxville, Tennessee, United States
View all 17 locations
View Trial Details
Recruiting

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

NCT07406633

Conditions
Digestive System Diseases, Digestive System Neoplasms, GIST, +12 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

NCT05957367

Conditions
Digestive System Diseases, Digestive System Neoplasms, GIST, +7 more
Locations
  • University of Southern California - Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • University of Massachusetts Worcester Worcester, Massachusetts, United States
View all 28 locations
View Trial Details

Related conditions